MedPath

Rapid and Accurate Detection of Major Mycobacterium Species in Pulmonary Infection Based on GenSeizer Platform

Conditions
Mycobacterium Pulmonary Infection
Interventions
Diagnostic Test: Detection method
Registration Number
NCT04345939
Lead Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Brief Summary

Comparison of rapid detection methods of mycobacterial pathogens, GenSeizer v.s. PCR reverse hybridization.

Detailed Description

The investigators developed a new platform called GenSeizer, which combines bioinformatics analysis of a large dataset with multiplex PCR-based targeted gene sequencing, to identify eleven major Mycobacterium species implicated in human disease. Simultaneous detection of certain antibiotic resistance genotypes, i.e., erm(41) and rrl in M. abscessus, is also feasible. This platform detected both reference strains and clinical isolates with a high degree of specificity and sensitivity.

In this study, the investigators plan to verify the detection efficiency of GenSeizer in clinical samples (sputum, alveolar lavage fluid) and compare it with existing methods on the market (PCR reverse hybridization) and gold standard method (target sequencing after incubation)

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Suspected cases of mycobacterial lung infection
Exclusion Criteria
  • No sputum
  • Refused or unable to tolerate bronchoscopy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
PCR reverse hybridizationDetection methodSputum and lavage fluids are tested for pathogens using PCR reverse hybridization
GenSeizerDetection methodSputum and lavage fluids are tested for pathogens using GenSeizer
Target sequencing after incubationDetection methodSputum and lavage fluids are tested for pathogens using Target sequencing after incubation
Primary Outcome Measures
NameTimeMethod
Detection accuracythrough study completion, an average of 3 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Haiqing Chu

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath